WASHINGTON — Digital health tools are developing faster than the Food and Drug Administration is able to regulate them, FDA Commissioner Robert Califf acknowledged this week.
“I think we’re behind, and it’s going to be really hard to catch up,” Califf said in a speech Monday at the National Health Council’s patient engagement symposium.
The central question of the conference was how to better bring patients into the process of developing and deploying new technologies. Algorithms have real sway over patients’ quality of care, offering information to support diagnoses and duration of treatment. They may trigger false alarms in predicting sepsis, or cut off care for seniors prematurely.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
